Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited)

v3.22.0.1
Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($)
Preferred Stock [Member]
Series A Preferred Stock [Member]
Preferred Stock [Member]
Series B Preferred Stock [Member]
Common Stock [Member]
Common Stock Issuable [Member]
Additional Paid-in Capital [Member]
Subscription Receivable [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Treasury Stock [Member]
Total
Beginning balance, value at Jun. 30, 2020 $ 5,000 $ 258 $ 50,913,893 $ (55,781,770) $ 1,267,671 $ (46,477) $ (3,641,425)
Balance, shares at Jun. 30, 2020 500,000 1 258,120            
Issuance of common stock for conversion of convertible debt and accrued interest $ 442 480,133 480,575
Issuance of common stock for conversion of convertible debt and accrued interest, shares     442,031              
Reclassification of put premium upon debt conversion 204,919 204,919
Issuance of common stock for exercise of warrants $ 15 201,029 201,044
Issuance of common stock for exercise of warrants, shares     15,445              
Stock based compensation in connection with fair value of warrants issued for services 20,718 20,718
Foreign currency translation loss (75,755) (75,755)
Net loss (425,545) (425,545)
Ending balance, value at Sep. 30, 2020 $ 5,000 $ 715 51,820,692 (56,207,315) 1,191,916 (46,477) (3,235,469)
Balance, shares at Sep. 30, 2020 500,000 1 715,596            
Beginning balance, value at Jun. 30, 2020 $ 5,000 $ 258 50,913,893 (55,781,770) 1,267,671 (46,477) (3,641,425)
Balance, shares at Jun. 30, 2020 500,000 1 258,120            
Foreign currency translation loss                   (243,520)
Net loss                   (829,188)
Ending balance, value at Dec. 31, 2020 $ 5,000 $ 1,447 $ 147 52,018,649 (56,610,958) 1,024,151 (46,477) (3,608,041)
Balance, shares at Dec. 31, 2020 500,000 1 1,446,834 147,158            
Beginning balance, value at Sep. 30, 2020 $ 5,000 $ 715 51,820,692 (56,207,315) 1,191,916 (46,477) (3,235,469)
Balance, shares at Sep. 30, 2020 500,000 1 715,596            
Issuance of common stock for conversion of convertible debt and accrued interest $ 703 141,126 141,829
Issuance of common stock for conversion of convertible debt and accrued interest, shares     702,623              
Reversal of common stock issuable due to cancellation of conversions of convertible debt and accrued interest $ (24) (19,992) (20,016)
Reversal of common stock issuable due to cancellation of conversions of convertible debt and accrued interest, shares     (24,427)              
Reversal of put premium upon cancellation of conversions of convertible debt (11,785) (11,785)
Issuance of common stock for alternate cashless exercise of warrants $ 53 $ 147 (200)
Issuance of common stock for alternate cashless exercise of warrants, shares     52,900 147,099            
Reclassification of put premium upon debt conversion 68,090 68,090
Vested restricted stock units
Vested restricted stock units, shares       59            
Foreign currency translation loss (167,765) (167,765)
Fractional difference due to the reverse stock-split
Fractional difference due to the reverse stock-split, shares     142              
Net loss (403,643) (403,643)
Stock based compensation in connection with stock option grants 20,718 20,718
Ending balance, value at Dec. 31, 2020 $ 5,000 $ 1,447 $ 147 52,018,649 (56,610,958) 1,024,151 (46,477) (3,608,041)
Balance, shares at Dec. 31, 2020 500,000 1 1,446,834 147,158            
Beginning balance, value at Jun. 30, 2021 $ 5,000 $ 14,056 54,074,110 (58,199,466) 1,085,204 (46,477) (3,067,573)
Balance, shares at Jun. 30, 2021 500,000 1 14,055,393 59            
Issuance of common stock for conversion of convertible debt and accrued interest $ 9,445 190,741 200,186
Issuance of common stock for conversion of convertible debt and accrued interest, shares     9,445,009              
Issuance of common stock for services and accrued expenses $ 17,934 563,927 581,861
Issuance of common stock for services and accrued expenses, shares     17,934,379              
Issuance of common stock for alternate cashless exercise of warrants $ 2,400 $ 2,000 (4,400)
Issuance of common stock for alternate cashless exercise of warrants, shares     2,399,988 1,999,990            
Reclassification of put premium upon debt conversion 109,643 109,643
Issuance of common stock for exercise of warrants $ 7 $ 2 374,991 (100,000) 275,000
Issuance of common stock for exercise of warrants, shares     6,875 2,500            
Foreign currency translation loss 64,193 64,193
Deemed dividend upon alternate cashless exercise of warrants 114,844 (114,844)
Net loss (490,658) (490,658)
Stock based compensation in connection with stock option grants 20,718 20,718
Ending balance, value at Sep. 30, 2021 $ 5,000 $ 43,842 $ 2,002 55,444,574 (100,000) (58,804,968) 1,149,397 (46,477) (2,306,630)
Balance, shares at Sep. 30, 2021 500,000 1 43,841,644 2,002,549            
Beginning balance, value at Jun. 30, 2021 $ 5,000 $ 14,056 54,074,110 (58,199,466) 1,085,204 (46,477) (3,067,573)
Balance, shares at Jun. 30, 2021 500,000 1 14,055,393 59            
Foreign currency translation loss                   56,496
Net loss                   (1,290,635)
Ending balance, value at Dec. 31, 2021 $ 5,000 $ 53,062 55,614,865 (59,698,343) 1,141,700 (46,477) (2,930,193)
Balance, shares at Dec. 31, 2021 500,000 1 53,062,209 59            
Beginning balance, value at Sep. 30, 2021 $ 5,000 $ 43,842 $ 2,002 55,444,574 (100,000) (58,804,968) 1,149,397 (46,477) (2,306,630)
Balance, shares at Sep. 30, 2021 500,000 1 43,841,644 2,002,549            
Issuance of common stock for conversion of convertible debt and accrued interest $ 1,818 24,908 26,726
Issuance of common stock for conversion of convertible debt and accrued interest, shares     1,818,097              
Issuance of common stock for alternate cashless exercise of warrants $ 6,400 $ (2,000) (4,400)
Issuance of common stock for alternate cashless exercise of warrants, shares     6,399,968 (1,999,990)            
Reclassification of put premium upon debt conversion 16,667 16,667
Issuance of common stock for deferred offering cost $ 1,000 19,000 20,000
Issuance of common stock for deferred offering cost, shares     1,000,000              
Issuance of common stock for exercise of warrants $ 2 $ (2) 100,000 100,000
Issuance of common stock for exercise of warrants, shares     2,500 (2,500)            
Foreign currency translation loss (7,697) (7,697)
Deemed dividend upon alternate cashless exercise of warrants 93,398 (93,398)
Net loss (799,977) (799,977)
Stock based compensation in connection with stock option grants 20,718 20,718
Ending balance, value at Dec. 31, 2021 $ 5,000 $ 53,062 $ 55,614,865 $ (59,698,343) $ 1,141,700 $ (46,477) $ (2,930,193)
Balance, shares at Dec. 31, 2021 500,000 1 53,062,209 59